The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Trenary C Russell Iii since 2006.
This trader's CIK number is 1227307.
At the time of last reporting, Trenary C Russell Iii was the CEO and President of Outlook Therapeutics, Inc.. (stock ticker symbol OTLK).
Also see all insider trading activities at Outlook Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | OTLK | 19,925 | $21,120 | 0 | $0 | 0 | $0 |
| 2021 | OTLK | 35,000 | $48,750 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2009 | EYE | 0 | $0 | 87,000 | $1,911,390 | 87,000 | $993,540 |
| 2008 | EYE | 0 | $0 | 1,000 | $24,201 | 1,000 | $8,990 |
| 2007 | EYE | 0 | $0 | 2,000 | $82,400 | 2,000 | $17,980 |
| 2006 | EYE | 0 | $0 | 10,000 | $423,380 | 10,000 | $89,900 |
1. Outlook Therapeutics, Inc. (OTLK)
2. Advanced Medical Optics Inc (EYE)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-06-21 | OTLK | Buy | 19,925 | 1.06 | 21,120 |
| 2021-12-06 | OTLK | Buy | 25,000 | 1.39 | 34,750 |
| 2021-12-02 | OTLK | Buy | 10,000 | 1.40 | 14,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-02-24 | EYE | Option Ex | 87,000 | 11.42 | 993,540 |
| 2009-02-24 | EYE | Sale | 87,000 | 21.97 | 1,911,390 |
| 2008-05-30 | EYE | Option Ex | 1,000 | 8.99 | 8,990 |
| 2008-05-30 | EYE | Sale | 1,000 | 24.20 | 24,201 |
| 2007-05-03 | EYE | Option Ex | 2,000 | 8.99 | 17,980 |
| 2007-05-03 | EYE | Sale | 2,000 | 41.20 | 82,400 |
| 2006-02-16 | EYE | Option Ex | 10,000 | 8.99 | 89,900 |
| 2006-02-16 | EYE | Sale | 10,000 | 42.34 | 423,380 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Trenary C Russell Iii (CEO and President of Outlook Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.